Literature DB >> 18197147

The peritoneum as a novel oxygenation organ: revitalization of intraperitoneal oxygenation.

Noriyuki Matsutani1, Bonpei Takase, Yashiro Nogami, Yuichi Ozeki, Masayuki Ishihara, Tadaaki Maehara.   

Abstract

Supplemental oxygenation is important in reversible pulmonary failure. To determine whether the peritoneal cavity can be used as a source of "extrapulmonary respiration," we perfused the peritoneal cavity with oxygenated red blood cells (RBCs) and saline, and measured the amount of oxygenation delivered through the peritoneum of dogs under controlled ventilation. Inflow and outflow catheters were placed in the peritoneal cavity and connected to a perfusion circuit. We investigated the safety of this procedure by examining the relationship between intraperitoneal infusion volume and hemodynamic changes in dogs that underwent peritoneal perfusion with oxygenated RBC (n = 6) and with oxygenated saline (n = 6). The controls comprised dogs that underwent a sham operation (n = 6). We found that an intraperitoneal infusion of less than 1,250 mL was hemodynamically safe. Oxygenation levels (PaO2) increased most obviously with an intraperitoneal infusion of oxygenated RBC. The peritoneum can potentially serve as an "artificial lung" in critically ill patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18197147     DOI: 10.1097/shk.0b013e318162be0a

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  2 in total

1.  Efficacy of peritoneal oxygenation using a novel artificial oxygen carrier (TRM-645) in a rat respiratory insufficiency model.

Authors:  Noriyuki Matsutani; Bonpei Takase; Yashiro Nogami; Yuichi Ozeki; Shinichi Kaneda; Tadaaki Maehara; Makoto Kikuchi; Masayuki Ishihara
Journal:  Surg Today       Date:  2010-04-28       Impact factor: 2.549

2.  Systemic oxygen delivery by peritoneal perfusion of oxygen microbubbles.

Authors:  Jameel A Feshitan; Nathan D Legband; Mark A Borden; Benjamin S Terry
Journal:  Biomaterials       Date:  2014-01-15       Impact factor: 12.479

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.